Clinigen - About the company
Clinigen is an acquired company based in Burton-on-trent (United Kingdom), founded in 2010. It operates as a Services in clinical trials & medicine supply. Clinigen has raised an undisclosed amount in funding. The company has 1416 active competitors, including 27 funded and 149 that have exited. Its top competitors include companies like CMIC HOLDINGS, IntegriChain and Fishawack.
Company Details
Clinigen Group is a specialty pharmaceutical and services company which consists of five synergistic businesses that provide medicines to patients through clinical trials, licensed and unlicensed routes. Its units include Clinigen Clinical Trial Services (CTS) which provides commercial medicines for patients in clinical trials; Idis Managed Access (MA) which manages early access to unlicensed investigational medicines; Idis Global Access (GA) which enables access to post-approved medicines in regions where they are not commercially available; Clinigen Specialty Pharmaceuticals (SP) which ensures continuity of supply to hospital pharmacists, doctors and patients; and Link Healthcare which provides local and regional commercial access to vitally important specialist Pharmaceutical and Medical Technology products.
- Website
- clinigengroup.com
- Email ID
- *****@clinigengroup.com
- Registered Address
- PITCAIRN HOUSE CROWN SQUARE,FIRST AVENUE,BURTON-ON-TRENT,ENGLAND,DE14 2WW
Key Metrics
Founded Year
2010
Location
Burton-on-trent, United Kingdom
Stage
Acquired
Latest Funding Round
Investors
Ranked
1st among 1416 active competitors
Employee Count
631 as on May 31, 2026
Investment & Acquisitions
Similar Companies
Exit Details
Acquired by Triton Partners (Dec 08, 2021)
Legal entities associated with Clinigen
Clinigen is associated with 4 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
CLINIGEN CONSULTING LIMITED CIN: 6407889 , United Kingdom, Active | Oct 23, 2007 | - | - | |
CLINIGEN LIMITED CIN: 6771928 , United Kingdom, Active | Dec 11, 2008 | - | - | |
CLINIGEN SP LIMITED CIN: 8588212 , United Kingdom, Active | Jun 26, 2013 | - | - | |
CLINIGEN GAP LIMITED CIN: 7869194 , United Kingdom, Active | Dec 01, 2011 | - | - |
Clinigen's acquisition details
Clinigen got acquired by Triton Partners on Dec 08, 2021 at an acquisition amount of $*****.
Click here to take a look at Clinigen's acquisition in detail
Sign up to download Clinigen's company profile
Clinigen's funding and investors
Clinigen has raised funding over 1 round. Its latest funding round was a Conventional Debt round on 2015 for $*****. 3 investors participated in its latest round. Clinigen has 5 institutional investors.
Here is the list of recent funding rounds of Clinigen:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
2015 | 5225 | Conventional Debt | 2640 | 7348 | 8845 | 3567 |
View details of Clinigen's funding rounds and investors
Clinigen's founders and board of directors
Founder? Claim ProfileClinigen's employee count trend
Clinigen has 631 employees as of May 26. Here is Clinigen's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Clinigen's Competitors and alternates
Top competitors of Clinigen include CMIC HOLDINGS, IntegriChain and Fishawack. Here is the list of Top 10 competitors of Clinigen, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Clinigen 2010, Burton-on-trent (United Kingdom), Acquired | Services in clinical trials & medicine supply | - | 59/100 | |
2nd | CMIC HOLDINGS 1985, Tokyo (Japan), Acquired | Contract service provider for biopharma companies | - | - | 58/100 |
3rd | IntegriChain 2005, Philadelphia (United States), Acquired | Pharma commercialization solutions: data, consulting, and technology for market access | $2M | 58/100 | |
4th | Fishawack 2001, Brighton (United Kingdom), Acquired | Provider of fully-integrated, cross-border services to global pharmaceutical organisations | $23.6M | - | 57/100 |
5th | Prescient Healthcare Group 2007, London (United Kingdom), Series B | Consulting services for product strategy and decision support | $12.7M | 56/100 | |
6th | Provider of instruments for biotech, pharmaceutical, and biomedical industries | $175K | 56/100 | ||
7th | Diaceutics 2005, Belfast (United Kingdom), Public | Analytics based integrator for precision medicine | - | 55/100 | |
8th | Science Group 1986, Cambridge (United Kingdom), Public | Provider of product development, regulatory, and advisory services alongside the design and manufacture of systems for the defence and audio sectors | - | 49/100 | |
9th | Sequence 2002, Morrisville (United States), Acquired | Consulting services provider | - | - | 49/100 |
10th | Oxford PharmaGenesis 1998, Oxford (United Kingdom), Acquired | Provider of medical affairs, marketing, communication, consultancy, and other services for healthcare sector | - | - | 48/100 |
Looking for more details on Clinigen's competitors? Click here to see the top ones
Clinigen's Investments and acquisitions
Clinigen has not made any investments yet. Clinigen has made 13 acquisitions.Here is the list of latest three $acquisitions:
Filter this list
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Sep 29, 2025 | Acquisition | 2010 | Parsippany Troy Hills (United States) | |
Aug 06, 2024 | Acquisition | 2007 | Glasgow (United Kingdom) | |
Nov 29, 2022 | Acquisition | 2012 | Durham (United States) |
See all acquisitions by Clinigen
Reports related to Clinigen
Here is the latest report on Clinigen's sector:
News related to Clinigen
Media has covered Clinigen for a total of 4 events in the last 1 year, 2 of them have been about people movement.
•
•
Clinigen finalises acquisition of SSI StrategyEuropean Pharmaceutical Manufacturer•Nov 27, 2025•Clinigen, SSI Strategy
•
Amulet Capital Announces Sale of SSI Strategy to ClinigenBusiness Wire•Sep 29, 2025•Clinigen, Amulet Capital Partners, SSI Strategy
•
•
MaaT Pharma Partners with Clinigen for Xervyteg® Commercialization in EuropeBusiness Wire•Jul 02, 2025•MaaT Pharma, Clinigen
•
•
Essential Pharma and Clinigen Expand Collaboration to Improve Patient Access in JAPACFinancial Post•Feb 06, 2025•Essential Pharma, Clinigen
•
Santhera Enters into Supply and Distribution Agreement for AGAMREE® (Vamorolone) with Clinigen GroupGlobeNewswire•Jan 06, 2025•Santhera, Clinigen
•
•
Clinigen acquires Kinesys Consulting to boost regulatory affairs expertisePharma Business International•Aug 07, 2024•Clinigen, Kinesys Consulting
Are you a Founder ?
FAQs about Clinigen
Explore our recently published companies
- Himsons - Vadodara based, 1988 founded, Unfunded company
- Com2uS Platform Corp - Unfunded company
- Just Print - Unfunded company